MARKET

TNDM

TNDM

Tandem Diabetes
NASDAQ

Real-time Quotes | Nasdaq Last Sale

102.76
-1.35
-1.30%
After Hours: 102.90 +0.14 +0.14% 18:03 07/10 EDT
OPEN
103.82
PREV CLOSE
104.11
HIGH
104.87
LOW
101.66
VOLUME
489.20K
TURNOVER
--
52 WEEK HIGH
106.18
52 WEEK LOW
43.69
MARKET CAP
6.18B
P/E (TTM)
-367.7881
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TNDM stock price target is 100.38 with a high estimate of 125.00 and a low estimate of 80.00.

EPS

TNDM News

More
Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement
Business Wire · 1d ago
Medtronic inks cross license deal with Tandem Diabetes Care
Seeking Alpha - Article · 1d ago
Medtronic, Tandem Diabetes Care Enter Into Patent Cross-License Agreement; No Terms Disclosed
Benzinga · 1d ago
JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community
Business Wire · 2d ago
Tandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020
Business Wire · 3d ago
Abbott Deal, UnitedHealth Coverage Push Up Tandem Shares
GuruFocus.com · 4d ago
Citigroup Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $120
Citigroup analyst Joanne Wuensch upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Neutral to Buy and raises the price target from $94 to $120.
Benzinga · 4d ago
Insider Weekends: With Latest Purchase Harold Hamm Owns 80% Of Continental Resources
Seeking Alpha - Article · 4d ago

Industry

Medical Equipment, Supplies & Distribution
-0.14%
Healthcare Equipment & Supplies
-0.35%

Hot Stocks

Symbol
Price
%Change

About TNDM

Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, developing and commercialization of products for people with insulin-dependent diabetes. The Company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim X2 Insulin Delivery System (t:slim X2), and its product offerings. The t:slim X2 is based on its technology platform and is capable of remote feature updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. Its products also include Basal-IQ technology and Control-IQ technology. The Basal-IQ technology is a predictive low glucose suspend feature that is designed to temporarily suspend insulin delivery to help reduce the frequency and duration of hypoglycemic events. The Control-IQ technology is a hybrid-closed loop feature, designed to help increase a user's time in targeted glycemic range.
More

Webull offers kinds of Tandem Diabetes Care Inc stock information, including NASDAQ:TNDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNDM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TNDM stock methods without spending real money on the virtual paper trading platform.